| __timestamp | Dr. Reddy's Laboratories Limited | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 4241601.57 |
| Thursday, January 1, 2015 | 42585000000 | 5392385.38 |
| Friday, January 1, 2016 | 45702000000 | 7370036.73 |
| Sunday, January 1, 2017 | 46372000000 | 14970357 |
| Monday, January 1, 2018 | 46910000000 | 31413266 |
| Tuesday, January 1, 2019 | 48890000000 | 72279461 |
| Wednesday, January 1, 2020 | 50129000000 | 183907682 |
| Friday, January 1, 2021 | 54559000000 | 307644000 |
| Saturday, January 1, 2022 | 62081000000 | 472132000 |
| Sunday, January 1, 2023 | 105931000000 | 709539000 |
| Monday, January 1, 2024 | 77201000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent companies: Argenx SE and Dr. Reddy's Laboratories Limited, from 2014 to 2023.
Dr. Reddy's Laboratories, a stalwart in the industry, has seen its SG&A expenses grow by approximately 173% over the decade, peaking in 2023. This reflects their aggressive expansion and market penetration strategies. In contrast, Argenx SE, a rising star, has experienced a staggering increase in SG&A expenses, growing over 16,000% from 2014 to 2023, highlighting its rapid growth and investment in innovation.
While Dr. Reddy's expenses dwarf those of Argenx, the latter's exponential growth trajectory is noteworthy. However, data for 2024 is incomplete, leaving room for speculation on future trends.
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Zoetis Inc. vs Dr. Reddy's Laboratories Limited: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Intra-Cellular Therapies, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? argenx SE or Pharming Group N.V.
Operational Costs Compared: SG&A Analysis of argenx SE and Viking Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Xencor, Inc.: Who Manages SG&A Costs Better?